I'm on another Biotech whose Phase II trials were so beneficial to the patient that 45 of the Trial patients Doctors have recommended they stay on the trial drug. The company has produced it for them. Some drugs can be fast tracked under one of the Orphan drug categories.
They don't call this sector the BioBank for nothing, I have other investors who wont touch a Biotech under ten years old.... I like to be in on the ground floor,, seems some on this forum bought when the basement was poured,,well done,, IMHO it's still cheap at 5c
Add to My Watchlist
What is My Watchlist?
